Arcus Biosciences RCUS
NYSE RCUS
$24.46 -0.76 (-3.01%)
At close: Oct 2, 2026 · 4:00 PM EDT

Arcus Biosciences (RCUS) Other Accumulated Expenses (2017 - 2026)

Updated

Arcus Biosciences (RCUS) posted Other Accumulated Expenses of $145 million for Q2 2026, up 31.8% from $110 million a year earlier and up 6.6% from the prior quarter.

Analysis

Arcus Biosciences (RCUS) Other Accumulated Expenses (2017 - 2026) Analysis & Trends

At the end of FY2025, Arcus Biosciences' Other Accumulated Expenses came in at $154 million, up 25.2% from FY2024.

  • Annual Other Accumulated Expenses shows a five-year compound annual growth rate of 53.1% (FY2020 to FY2025).
  • In prior years, Arcus Biosciences' Other Accumulated Expenses was $123 million in FY2024 (+61.8%), $76 million in FY2023 (unchanged), $76 million in FY2022 (+40.7%) and $54 million in FY2021 (+195.0%).
  • Quarterly Other Accumulated Expenses has run from a low of $35.02 million in Q2 2022 to a high of $154 million in Q4 2025 over five years.
  • On a year-over-year basis, Other Accumulated Expenses has increased in each of the last ten quarters, with growth averaging 41.5% over the last eight quarters.
  • The strongest year-over-year quarter for Other Accumulated Expenses in the past five years was Q4 2021, with growth of 195.0%; the weakest was Q3 2022, with a decline of 1.6%.
  • According to Business Quant data, Other Accumulated Expenses for the three prior quarters was $136 million (Q1 2026), $154 million (Q4 2025) and $141 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Arcus Biosciences 3.11 Bn -229.58 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 145.00 Mn
Mar 31, 2026 136.00 Mn
Dec 31, 2025 154.00 Mn
Sep 30, 2025 141.00 Mn
Jun 30, 2025 110.00 Mn
Mar 31, 2025 98.00 Mn
Dec 31, 2024 123.00 Mn
Sep 30, 2024 97.00 Mn
Jun 30, 2024 71.00 Mn
Mar 31, 2024 64.00 Mn
Dec 31, 2023 76.00 Mn
Sep 30, 2023 80.00 Mn
Jun 30, 2023 65.00 Mn
Mar 31, 2023 54.00 Mn
Dec 31, 2022 76.00 Mn
Sep 30, 2022 39.83 Mn
Jun 30, 2022 35.02 Mn
Mar 31, 2022 37.65 Mn
Dec 31, 2021 54.00 Mn
Sep 30, 2021 40.47 Mn
API Access

Arcus Biosciences Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=RCUS&period=max&api_key=YOUR_API_KEY